Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study

Study found delayed 2nd dose strategy was optimal for vaccine efficacies at or >80% and vaccination rates at or <0.3% of population per day; for people aged < 65, delayed dose could result in reduced cumulative mortality under certain conditions.

Source:

British Medical Journal